“..On February 2026, a federal appeals court pushed back on the government in a case that could quietly matter a lot to people living with chronic pain..”
republished in youarewithinthenorms.com
RE: Imagine THIS: court said the DEA had overstepped its authority
NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, IN THE SPIRIT OF WALTER R. CLEMENT MS., MBA., BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., IN THE SPIRIT OF REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF WILLIE GUINYARD BS., IN THE SPIRIT OF ERLIN CLEMENT SR., JOSEPH WEBSTER MD., MBA, IN THE SPIRIT OF RICHARD KAUL, MD., BEVERLY C. PRINCE MD., FACS., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, IN THE SPIRIT OF WALTER F. WRENN III, MD., ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NDJOU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
THE FIFTH CIRCUIT COURT DECISION CURTAILS D.E.A, FLORIDA, TEXAS, MONTANA, AND CALIFORNIA PHARMACY BOARDS’ CLIMATE OF FEARS
The court said: That’s not what the regulation actually says.
FEDERAL COURT APPEALS RULINGS RESTRICTS THE D.E.A.’s ABILITY TO PENALIZE PHARMACIES
This legal summary explores a pivotal federal appeals court ruling that restricts the DEA’s ability to penalize pharmacies based on subjective or unwritten standards. In a significant legal shift, a federal appeals court recently ruled that the Drug Enforcement Administration (DEA) exceeded its legal boundaries when penalizing a local pharmacy.
Pharmacists still have duties, but they are not supposed to act as a second medical board overriding pain specialists out of fear.
The court determined that the agency cannot punish pharmacists based on what they “should have known,” but must instead prove that they knowingly filled illegitimate prescriptions.
This decision clarifies that federal drug laws are distinct from state-level negligence, preventing the DEA from revoking licenses over minor documentation errors or rules meant for physicians. By reigning in this unauthorized regulatory expansion, the ruling aims to reduce the climate of fear that has led many pharmacies to refuse legitimate pain medication.
Consequently, chronic pain patients may face fewer unjustified obstacles, as pharmacists feel more secure in relying on a doctor’s medical judgment. While the DEA maintains its authority to stop actual drug diversion, it must now adhere strictly to the written text of federal regulations.
Posted on March 1, 2026, by Pharmaciststeve
In February 2026, a federal appeals court pushed back on the government in a case that could quietly matter a lot to people living with chronic pain.
The case involved a small Louisiana pharmacy called Neumann’s Pharmacy. The Drug Enforcement Administration (DEA) had revoked the pharmacy’s license to dispense controlled substances, essentially shutting down a major part of its business. The pharmacy challenged that decision — and won.
The ruling came from the Fifth Circuit Court of Appeals in a case called Neumann’s Pharmacy, L.L.C. v. Drug Enforcement Administration. The court said the DEA had overstepped its authority and applied standards that weren’t actually written in federal law.
“..The fundamental thing that you need to understand here, from what I’m saying, is that these two assumptions conflate distinct causal pathways that are separated in time, and by this, I’m talking about four possible causal pathways, and I’m generalizing here. But this is kind of where we think you know the paths, we think, where uh medical opioid exposure may subsequently be associated with overdose uh overdose deaths, and this is again not a high um. It’s not a high-frequency event in our studies..” dr. nabaron dasgupta ph.d
Here’s what that means in plain English.
⸻
What the Court Said:
1. The DEA Can’t Punish Pharmacists for “You Should Have Known.”
Under federal law (the Controlled Substances Act), pharmacists have what’s called a “corresponding responsibility.” That means they share responsibility with doctors to make sure prescriptions for controlled drugs — like opioids — are legitimate.
But the DEA had been using a broad standard. It would penalize pharmacies if a pharmacist “knew or should have known” a prescription might be invalid.
The court said: That’s not what the regulation actually says.
Instead, the DEA must now prove that the pharmacist actually knew the prescription was invalid.
That’s a big difference.
Example:
Imagine a pain patient who has been on a high dose of opioids for 10 years. The prescription looks high-risk on paper. Under the DEA’s old approach, a pharmacist might think, “This looks suspicious. If I fill it and something’s wrong, I could lose my license.” So they refuse to fill it — even if the doctor carefully documented the medical need.
Now, the DEA would have to prove the pharmacist knew the prescription was improper — not just that they might have suspected something.
“That reduces fear-based refusals.“
⸻
2. Federal Law Is Not the Same as State Negligence
The DEA also argued that if a pharmacy fell below a state’s “standard of care” (basically, what a reasonable professional should do), that automatically meant it violated federal law.
The court said: No. Those are not the same thing.
A paperwork mistake or even a state-level negligence issue does not automatically become a federal drug crime.
Example:
If a pharmacist forgets to fully document how they resolved a “red flag” in a patient’s file, that might be sloppy — but it’s not automatically proof they knowingly filled an illegitimate prescription.
Before this ruling, pharmacies feared that minor documentation lapses could cost them their federal registration. The court said federal enforcement must stick to the actual text of federal regulations — not expand them.
⸻
3. The DEA Misapplied a State Rule
In this case, the DEA also relied on a Louisiana rule that says doctors generally shouldn’t prescribe controlled substances to family members.
The problem? That rule applies to doctors, not pharmacies.
The court said the DEA improperly applied a rule intended for prescribers to punish a pharmacy.
In everyday terms:
You can’t penalize the mail carrier for a rule that applies to the sender.
⸻
The DEA still has power — but it is not “boundless.” It must follow the exact language of its own rules
The “Red Flags” Issue
The DEA originally targeted the pharmacy for filling prescriptions with so-called “red flags.” These included combinations like opioids plus benzodiazepines — sometimes called “drug cocktails.”
Those combinations can be dangerous. But they’re also sometimes medically necessary.
In recent years, pharmacies across the country have become extremely cautious. Many refused:
• High-dose opioid prescriptions
• Long-term opioid therapy
• Opioid + benzodiazepine combinations
• Prescriptions from pain specialists or out-of-town doctors
Not necessarily because they believed the prescriptions were fake — but because they feared DEA enforcement.
The court made clear:
The DEA still has power — but it is not “boundless.” It must follow the exact language of its own rules.
the pharmacological holy trinity
⸻
What This Means for Chronic Pain Patients
For people living with chronic pain, the biggest issue over the last decade hasn’t just been doctors stopping prescriptions — it’s been pharmacies refusing to fill them.
This ruling may ease some of that.
1. Less Second-Guessing of Doctors
Example:
A patient with severe spinal damage has been stable for years on a carefully monitored opioid plan. Under the previous enforcement climate, a pharmacist might refuse to fill it because the dose “looks high.” After this ruling, pharmacists may feel safer relying on the doctor’s documented judgment.
⸻
2. Fewer Fear-Based Refusals
Previously, pharmacists risked punishment if regulators believed they “should have known” something was wrong.
Now, regulators must show actual knowledge of wrongdoing.
That reduces what many patients have experienced as the “chilling effect” — pharmacies declining legitimate prescriptions simply to avoid risk.
⸻
3. Harder for the DEA to Shut Down Pharmacies Over Minor Issues
The ruling makes it more difficult for the DEA to revoke a pharmacy’s license based on:
• Minor documentation gaps
• Disagreements over pain management philosophy
• Technical state-law issues
That matters because when a pharmacy loses its DEA registration, entire communities lose access — including legitimate pain patients.
⸻
What Has NOT Changed
This is not a free pass.
• Pharmacists still must identify obvious signs of diversion (for example, forged prescriptions).
• High-dose opioid prescriptions still receive scrutiny.
• Federal documentation requirements remain strict.
• Telehealth prescribing rules still require in-person evaluations in many situations.
• State opioid caps (like Maine’s 100 MME limit) are unaffected.
The DEA still has significant authority — it just can’t expand its rules beyond what the law actually says.
⸻
The Bigger Picture
NEUMANNS’ PHARMACY: A FEDERAL COURT APPEALS SMACKDOWN !!!
*A LEGAL FICTION*
OF D.E.A. AND THE FATAL MISDIRECTION OF OUR STATE BOARDS OF PHARMACY
For chronic pain patients, this ruling doesn’t guarantee easy access to medication.
But it may restore a measure of balance.
For years, many pharmacists felt they had to protect themselves first and patients second. This decision signals that federal regulators must prove real misconduct — not just suspicion.
In practical terms, that could mean:
• Fewer abrupt pharmacy refusals
• More reliance on physician judgment
• Less fear-driven decision-making
It doesn’t undo the opioid crisis policies of the past decade. But it draws a clearer line around federal power — and for some patients, that line could mean the difference between treatment and untreated pain.
🔓 🔓 🔓
ALL WATCHED OVER BY MACHINES OF LOVING GRACE
BE SURE TO DONATE TO THE MARK IBSEN GOFUNDME DEFENSE FUND, WHERE THE SON ALWAYS RISES!!!
OUR TREE OF KNOWLEDGE SHALL NEVER BE SUPPRESSED
FOR NOW, YOU ARE WITHIN
THE NORMS
REFERENCES:
The Pharmacist’s Dilemma December 19, 2025
..Law enforcement agencies have raided and arrested medical personnel for filling legally prescribed medications, particularly controlled medications of patients being treated for acute and chronic pain diseases.“
